Saturday, August 13, 2022 | Back issues
Courthouse News Service Courthouse News Service

Diabetes Drugs

A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers monopoly claims may continue, but their antitrust claims fail. 

NEW YORK – A federal court in New York dismissed all but one claim against a pharmaceutical company in a suit claiming it inflated the prices of two diabetes drugs. The purchasers' monopoly claims may continue, but their antitrust claims fail. 

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...